TapImmune Inc. (TPIV) Appoints Leading Immunotherapy Researcher to Chair Scientific Advisory Board
6/13/2014 7:29:08 AM
TapImmune Inc. (OTCQB:TPIV) is pleased to announce that Dr. Keith Knutson, PhD (www.vgtifl.org/keith-knutson-phd) has been appointed to chair the company’s scientific advisory board. Dr. Knutson is Director of the Cancer Vaccines and Immune Therapies Program at the Vaccine & Gene Therapy Institute of Florida, a nonprofit biomedical research institute in Port St. Lucie, FL (VGTI Florida).
Help employers find you! Check out all the jobs and post your resume.
comments powered by